THANK YOU FOR SUBSCRIBING


Yutaka Ise, President & Representative Director*Introduction of EP-PharmaLine (https://www.pharmatechoutlook.com/ep-pharmaline)
Firstly, "hospitality" is important in realizing personalized medicine in Japan. It is not just responding to what is heard from healthcare professionals and patients, but understanding the background of the question and quickly leading to the answer that corresponds to the essential needs. This requires not only specialized knowledge to solve problems, but also listening skills and empathy. Without daily studies, it is impossible to equip and respond to all of these. EP-PharmaLine maintains a high level of customer satisfaction by developing human resources who are the core of this call center response. Specifically, we are implementing unique human resource development programs and in-house certification specifically for medical communicators. These initiatives have been highly evaluated at the Call Center Awards, which many call center companies from various industries gather, and we have won multiple awards.
In addition, as mentioned earlier, our BCP is well-prepared to cover the frequent earthquakes in Japan. For example, the building where the call center is located is equipped with its own generator, which allows it to operate for a certain period even in the event of a power outage. Furthermore, it is possible to work from home as needed and operate at different locations. Our call centers are in several major cities in Japan, including Tokyo, Osaka, and Fukuoka.
Next, we are proud to introduce our distinctive products. The distribution of ethical drugs in Japan is mostly done through pharmaceutical wholesalers. Therefore, to smoothly deliver medical care to patients, it is also important to cooperate with pharmaceutical companies and wholesalers. In Japan, there are drugs that are subject to distribution conditions imposed by the authorities for several years after their release.
"EP-Judge®" is a system developed by EP-PharmaLine that allows you to directly input necessary conditions such as the names of drugs with distribution conditions on the web, the names of facilities expected to be delivered, etc., and automatically determine and confirm whether it can be delivered. Up until now, even though there are many stakeholders to share information about distribution management, everything was done by analogue (human) methods and there were various issues. By replacing it with EP-Judge, the time from order to delivery can be reduced by 50-80%, and the cost of human resources can be reduced with the reduction of labor hours. It can also be operated from home as a BCP, and even in the event of a disaster, a stable supply of drugs can be realized. Currently, about 96% of wholesalers who are members of the Japan Pharmaceutical Wholesalers Association have introduced this system, and we believe that this system will become the standard in the industry, creating value for the entire pharmaceutical industry and patients waiting for medicines.
We also have a remote detailing service called ES Navigation®, which provides information about medicines in coordination with Suzuken MS (Marketing specialist at Suzuken, a leading pharmaceutical wholesaler in Japan), for regions and medical institutions that are difficult for MRs to access. This is a unique service that combines the mobility of MS, who enters and leaves medical institutions every day to deliver medicines, and the expertise of EP-PharmaLine. We have a track record of successful implementations in over 10 pharmaceutical companies so far and have contributed to the increase in product sales.
At EP-PharmaLine, we can accept all post-manufacturing sales services. Entrusting everything to us, like EPPV, PMS, creation of promotional materials, call center, remote detailing, regulation review etc., can lead to a reduction in load and efficiency when outsourcing operations from pharmaceutical companies.
Moreover, the EPS Group, to which EP-PharmaLine belongs, also has functions such as CRO and SMO, enabling us to handle everything from pharmaceutical research and development to post-marketing within the group.
As a professional vendor in Japanese healthcare sector with a full understanding of the pharmaceutical industry, we can make unique proposals.
Based on these extensive achievements, experiences, and distinctive initiatives, we are committed to maximizing the activities of pharmaceutical companies and medical device companies in Japan, meeting the needs of global companies, and contributing to the advancement of healthcare in Japan.